Tiagabine Hydrochloride Tablet shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting Apr 15, 2026 · last update Apr 15, 2026
Manufacturers: Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Apr 15, 2026 Updated Apr 15, 2026 Discontinued Apr 15, 2026 |
| Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Apr 15, 2026 Updated Apr 15, 2026 Discontinued Apr 15, 2026 |
| Tiagabine Hydrochloride, Tablet, 12mg 30 count (NDC 0093-8072-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Apr 15, 2026 Updated Apr 15, 2026 Discontinued Apr 15, 2026 |
| Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Apr 15, 2026 Updated Apr 15, 2026 Discontinued Apr 15, 2026 |